BMS-986419
/ BMS, Evotec
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
November 18, 2025
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
(clinicaltrials.gov)
- P1 | N=74 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed
Trial completion
July 26, 2025
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
(clinicaltrials.gov)
- P1 | N=74 | Recruiting | Sponsor: Bristol-Myers Squibb | Trial completion date: Jun 2025 ➔ Oct 2025 | Trial primary completion date: Jun 2025 ➔ Oct 2025
Trial completion date • Trial primary completion date
April 01, 2025
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
(clinicaltrials.gov)
- P1 | N=74 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open
February 26, 2025
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
(clinicaltrials.gov)
- P1 | N=74 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P1 trial
January 23, 2024
A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=60 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed
Trial completion
October 30, 2023
A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
(clinicaltrials.gov)
- P1 | N=22 | Completed | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Completed
Trial completion
October 02, 2023
A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants
(clinicaltrials.gov)
- P1 | N=8 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed
Trial completion
August 29, 2023
A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=60 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open
July 27, 2023
A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P1 trial
1 to 9
Of
9
Go to page
1